W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH PROPATEN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY
|
Back to Search Results |
|
Catalog Number PAHR072502E |
Device Problems
Break (1069); Difficult to Remove (1528)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/21/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
No patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.Cbas® heparin surface incorporates carmeda heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
|
Event Description
|
The following information was reported to gore: on (b)(6) 2023, the patient presented with afs (superficial femoral artery) occlusion.Reportedly the patient was treated successfully with a gore® viabahn® endoprosthesis with propaten bioactive surface device.After successful placement of the device, during retrieval, while still in patient, the delivery system (the part where the viabahn is on "distal part"), came apart of the delivery system.Eventually the whole system (still attached to wire together with the sheath, the separated distal part) was pulled out of the patient.The reporting fsa stated that the sheath was sized according to the ifu and no catheter fragments remained in patient.The physician stated the possible cause of the event was bad connection of our device.
|
|
Manufacturer Narrative
|
The engineering evaluation report details observations made directly on the returned device in addition to device photos captured during evaluation.Engineering evaluation of the device confirms the reported failure mode of separated distal shaft.The root cause of the separated distal shaft could not be established with the available information.There is evidence of a bond occurring within the transition.The root cause of the kink in distal shaft is consistent with manipulation during procedure.Emdr section h6 codes updated to reflect results of investigation.
|
|
Search Alerts/Recalls
|
|
|